Elixinol Wellness Past Earnings Performance
Past criteria checks 0/6
Elixinol Wellness has been growing earnings at an average annual rate of 54.8%, while the Personal Products industry saw earnings growing at 8.7% annually. Revenues have been declining at an average rate of 33.9% per year.
Key information
54.8%
Earnings growth rate
68.7%
EPS growth rate
Personal Products Industry Growth | -25.2% |
Revenue growth rate | -33.9% |
Return on equity | -92.4% |
Net Margin | -59.3% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elixinol Wellness makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 12 | -7 | 9 | 0 |
31 Mar 24 | 10 | -7 | 9 | 0 |
31 Dec 23 | 8 | -8 | 9 | 0 |
30 Sep 23 | 8 | -7 | 10 | 0 |
30 Jun 23 | 7 | -7 | 10 | 0 |
31 Mar 23 | 7 | -9 | 11 | 0 |
31 Dec 22 | 7 | -11 | 13 | 0 |
30 Sep 22 | 7 | -12 | 14 | 0 |
30 Jun 22 | 8 | -13 | 16 | 0 |
31 Mar 22 | 9 | -15 | 17 | 0 |
31 Dec 21 | 9 | -17 | 19 | 0 |
30 Sep 21 | 11 | -21 | 20 | 0 |
30 Jun 21 | 12 | -25 | 22 | 0 |
31 Mar 21 | 13 | -65 | 25 | 0 |
31 Dec 20 | 15 | -105 | 29 | 0 |
30 Jun 20 | 21 | -161 | 37 | 0 |
31 Mar 20 | 26 | -121 | 38 | 0 |
31 Dec 19 | 31 | -80 | 39 | 0 |
30 Jun 19 | 35 | -10 | 29 | 0 |
31 Mar 19 | 34 | -5 | 23 | 0 |
31 Dec 18 | 32 | 0 | 17 | 0 |
Quality Earnings: EXL is currently unprofitable.
Growing Profit Margin: EXL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EXL is unprofitable, but has reduced losses over the past 5 years at a rate of 54.8% per year.
Accelerating Growth: Unable to compare EXL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EXL is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.2%).
Return on Equity
High ROE: EXL has a negative Return on Equity (-92.37%), as it is currently unprofitable.